[Action of the (nitro-5 thiazolyl-2)-1 imidazolidine thione-2 (26354 R.P.) on experimental bilharziasis in laboratory animals].
D000284:Administration, Oral; D000367:Age Factors; D000818:Animals; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004353:Drug Evaluation, Preclinical; D004361:Drug Tolerance; D005260:Female; D008251:Macaca; D008297:Male; D051379:Mice; D009560:Niridazole / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D009593:Nitroimidazoles / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D010270:Parasite Egg Count; D051381:Rats; D012550:Schistosoma mansoni / Q000187:drug effects*; D012552:Schistosomiasis / Q000188:drug therapy*; D012737:Sex Factors
D009593:Nitroimidazoles; D009560:Niridazole
Activité de la (nitro-5 thiazolyl-2)-1 imidazolidine thione-2 (26354 R.P.) sur la bilharziose expérimentale des animaux de laboratoire